Pharmacognosy Research logo
Review

Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds

1, 1,2★★ Corresponding author

  1. 1Department of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009
  2. 2Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, China

CORRESPONDENCE

YU Feng

Department of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009

yufengcpu14@gmail.com

Volume 7, Issue 3 · pp. 225-236 · 2015 · DOI: 10.4103/0974-8490.157957

ABSTRACT

Polygonum multiflorum Thunb. (PMT), officially listed in the Chinese Pharmacopoeia, is one of the most popular perennial Chinese traditional medicines known as He shou wu in China and East Asia, and as Fo-ti in North America. Mounting pharmacological studies have stressed out its key benefice for the treatment of various diseases and medical conditions such as liver injury, cancer, diabetes, alopecia, atherosclerosis, and neurodegenerative diseases as well. International databases such as PubMed/Medline, Science citation Index and Google Scholar were searched for clinical studies recently published on P. multiflorum. Various clinical studies published articles were retrieved, providing information relevant to pharmacokinetics-pharmacodynamics analysis, sleep disorders, dyslipidemia treatment, and neurodegenerative diseases. This review is an effort to update the clinical picture of investigations ever carried on PMT and/or its isolated bio-compounds and to enlighten its therapeutic assessment.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Bounda, G., & Feng, Y. (2015). Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds. Pharmacognosy Research, 7(3), 225-236. https://doi.org/10.4103/0974-8490.157957

    Copyright and licence

    © 2015 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0